RNAZ: Transcode Therapeutics Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Transcode Therapeutics Inc (RNAZ).
$1.76M Market Cap.
RNAZ Market Cap. (MRY)
RNAZ Shares Outstanding (MRY)
RNAZ Assets (MRY)
Total Assets
$7.29M
Total Liabilities
$9.31M
Total Investments
$0
RNAZ Income (MRY)
Revenue
$0
Net Income
-$16.75M
Operating Expense
$15.66M
RNAZ Cash Flow (MRY)
CF Operations
-$13.34M
CF Investing
-$21.76K
CF Financing
$16.40M
RNAZ Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $7,294,499 (41.10%) | $5,169,701 (-31.87%) | $7,587,986 (-66.92%) | $22,938,443 (2073.50%) |
Assets Current | $7,093,338 (59.21%) | $4,455,444 (-39.62%) | $7,379,405 (-67.54%) | $22,732,175 (2634.81%) |
Assets Non-Current | $201,161 (-71.84%) | $714,257 (242.44%) | $208,581 (1.12%) | $206,268 (-7.98%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | -$2,018,734 (-223.03%) | $1,640,814 (-49.37%) | $3,240,696 (-84.12%) | $20,404,346 (698.68%) |
Property Plant & Equipment Net | $89,305 (-85.18%) | $602,401 (188.81%) | $208,581 (1.12%) | $206,268 (0%) |
Cash & Equivalents | $5,811,064 (109.97%) | $2,767,598 (-44.30%) | $4,968,418 (-76.14%) | $20,825,860 (2415.15%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $25,408 (-6.09%) | $27,057 (0%) | $0 (0%) | $30,528 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $360,229 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $2,708,137 (-11.25%) | $3,051,259 (-29.81%) | $4,347,290 (73.64%) | $2,503,569 (518.38%) |
Accumulated Retained Earnings (Deficit) | -$63,201,916 (-36.16%) | -$46,416,344 (-66.54%) | -$27,870,249 (-170.45%) | -$10,305,281 (-197.68%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $38,291 (-91.50%) | $450,571 (0%) | $0 (0%) | $0 (0%) |
Debt Current | $38,291 (-90.71%) | $412,280 (0%) | $0 (0%) | $0 (0%) |
Debt Non-Current | $0 (0%) | $38,291 (0%) | $0 (0%) | $0 (0%) |
Total Liabilities | $9,313,233 (163.91%) | $3,528,887 (-18.83%) | $4,347,290 (71.55%) | $2,534,097 (-43.23%) |
Liabilities Current | $2,771,836 (-20.59%) | $3,490,596 (-19.71%) | $4,347,290 (71.55%) | $2,534,097 (525.92%) |
Liabilities Non-Current | $6,541,397 (16983.38%) | $38,291 (0%) | $0 (0%) | $0 (0%) |
RNAZ Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $5,954,339 (-16.78%) | $7,154,986 (-15.16%) | $8,433,448 (148.25%) | $3,397,169 (668.34%) |
Research & Development Expense | $9,706,358 (-20.85%) | $12,263,530 (19.85%) | $10,232,366 (271.55%) | $2,753,966 (868.14%) |
Operating Expenses | $15,660,697 (-19.35%) | $19,418,516 (4.03%) | $18,665,814 (203.45%) | $6,151,135 (746.56%) |
Interest Expense | $26,813 (-52.03%) | $55,899 (0%) | $0 (0%) | $95,070 (-75.91%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$16,754,971 (9.66%) | -$18,546,095 (-5.59%) | -$17,564,968 (-156.67%) | -$6,843,399 (-191.97%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$16,754,971 (9.66%) | -$18,546,095 (-5.59%) | -$17,564,968 (-156.67%) | -$6,843,399 (-191.97%) |
Preferred Dividends Income Statement Impact | $30,601 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$16,785,572 (9.49%) | -$18,546,095 (-5.59%) | -$17,564,968 (-156.67%) | -$6,843,399 (-191.97%) |
Weighted Average Shares | $356,115 (98.94%) | $179,006 (-72.41%) | $648,862 (54.02%) | $421,294 (81.74%) |
Weighted Average Shares Diluted | $356,115 (98.94%) | $179,006 (-72.41%) | $648,862 (54.02%) | $421,294 (81.74%) |
Earning Before Interest & Taxes (EBIT) | -$16,728,158 (9.53%) | -$18,490,196 (-5.27%) | -$17,564,968 (-160.29%) | -$6,748,329 (-246.19%) |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$15,660,697 (19.35%) | -$19,418,516 (-4.03%) | -$18,665,814 (-203.45%) | -$6,151,135 (-746.56%) |
RNAZ Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$21,761 (38.89%) | -$35,609 (64.72%) | -$100,919 (59.92%) | -$251,820 (0%) |
Net Cash Flow from Financing | $16,401,174 (3.09%) | $15,909,324 (265542.41%) | $5,989 (-99.98%) | $25,516,549 (2185.37%) |
Net Cash Flow from Operations | -$13,335,947 (26.22%) | -$18,074,535 (-14.67%) | -$15,762,512 (-199.28%) | -$5,266,885 (-968.40%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $3,043,466 (238.29%) | -$2,200,820 (86.12%) | -$15,857,442 (-179.30%) | $19,997,844 (3107.12%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | -$21,761 (38.89%) | -$35,609 (64.72%) | -$100,919 (59.92%) | -$251,820 (0%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $16,401,174 (3.09%) | $15,909,324 (265542.41%) | $5,989 (-99.98%) | $26,377,492 (0%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $1,699,999 (63.95%) | $1,036,889 (162.29%) | $395,329 (112.55%) | $185,996 (309.29%) |
Depreciation Amortization & Accretion | $534,857 (3.50%) | $516,746 (424.05%) | $98,606 (132.18%) | $42,470 (0%) |
RNAZ Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | - | - | - |
Profit Margin | - | - | - | - |
EBITDA Margin | - | - | - | - |
Return on Average Equity (ROAE) | -1212.00% (-29.67%) | -934.70% (-444.38%) | -171.70% (-92.49%) | -89.20% (-185.93%) |
Return on Average Assets (ROAA) | -287.60% (-4.17%) | -276.10% (-106.66%) | -133.60% (-148.33%) | -53.80% (85.54%) |
Return on Sales (ROS) | - | - | - | - |
Return on Invested Capital (ROIC) | 2147.20% (19.93%) | 1790.40% (-20.09%) | 2240.40% (475.65%) | -596.40% (-324.48%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% |
Price to Earnings Ratio (P/E) | 0 (0%) | -0.06 (87.17%) | -0.5 (84.09%) | -3.14 |
Price to Sales Ratio (P/S) | - | - | - | - |
Price to Book Ratio (P/B) | -0.87 (-143.24%) | 2.02 (-25.08%) | 2.69 (67.81%) | 1.61 |
Debt to Equity Ratio (D/E) | -4.61 (-314.46%) | 2.15 (60.40%) | 1.34 (981.45%) | 0.12 (109.47%) |
Earnings Per Share (EPS) | -16,785,572 (-16200625.80%) | -103.61 (-283.74%) | -27 (-66.67%) | -16.2 (-58.82%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -37.51 (62.92%) | -101.17 (-313.82%) | -24.45 (-86.64%) | -13.1 (-515.84%) |
Book Value Per Share (BVPS) | -5.67 (-161.85%) | 9.17 (83.54%) | 4.99 (-89.69%) | 48.43 (429.41%) |
Tangible Assets Book Value Per Share (TABVPS) | 20.48 (-29.07%) | 28.88 (146.96%) | 11.69 (-78.52%) | 54.45 (1095.87%) |
Enterprise Value Over EBIT (EV/EBIT) | 0 (0%) | 0 (0%) | 0 (0%) | -2 |
Enterprise Value Over EBITDA (EV/EBITDA) | -0 (-101.02%) | 0.2 (6466.67%) | 0 (100.20%) | -1.53 |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 2.56 (100.55%) | 1.28 (-24.81%) | 1.7 (-81.08%) | 8.97 (336.97%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$13,357,708 (26.24%) | -$18,110,144 (-14.16%) | -$15,863,431 (-187.45%) | -$5,518,705 (-1019.48%) |
Enterprise Value (EV) | $39,809 (101.12%) | -$3,546,156 (-6136.43%) | -$56,862 (-100.55%) | $10,277,762 |
Earnings Before Tax (EBT) | -$16,754,971 (9.66%) | -$18,546,095 (-5.59%) | -$17,564,968 (-156.67%) | -$6,843,399 (-191.97%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$16,193,301 (9.90%) | -$17,973,450 (-2.90%) | -$17,466,362 (-160.46%) | -$6,705,859 (-244.01%) |
Invested Capital | -$1,250,110 (-95.97%) | -$637,922 (63.08%) | -$1,727,722 (-309.88%) | -$421,514 (-122.08%) |
Working Capital | $4,321,502 (347.89%) | $964,848 (-68.18%) | $3,032,115 (-84.99%) | $20,198,078 (4637.41%) |
Tangible Asset Value | $7,294,499 (41.10%) | $5,169,701 (-31.87%) | $7,587,986 (-66.92%) | $22,938,443 (2073.50%) |
Market Capitalization | $1,763,190 (-46.76%) | $3,312,084 (-62.08%) | $8,733,678 (-73.35%) | $32,777,618 |
Average Equity | $1,385,000 (-30.19%) | $1,984,095 (-80.60%) | $10,228,484 (33.36%) | $7,669,562 (439.51%) |
Average Assets | $5,836,415 (-13.11%) | $6,717,400 (-48.93%) | $13,152,258 (3.44%) | $12,714,722 (1918.47%) |
Invested Capital Average | -$779,082 (24.56%) | -$1,032,743 (-31.73%) | -$784,008 (-169.29%) | $1,131,497 (-18.42%) |
Shares | 523,202 (4.13%) | 502,440 (-22.57%) | 648,862 (0.56%) | 645,229 (7.83%) |
